AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 DEC 19 - (NewsRx.com & NewsRx.net) -- American Biogenetic Sciences, Inc., (MABA, ABS) has negotiated a 10-year agreement with the Ministry of Health of the Russian Federation covering human vaccines for anthrax, smallpox, botulism and other diseases. A second agreement with the Russian Agricultural Academy extends ABS' rights for livestock vaccines, including one for animal anthrax.
The agreements govern vaccine distribution to specified global territories including North America, South America, the European Community, and the Pacific Rim.
"This is a very significant partnership given recent events in the United States and the imminent and real threat of bioterrorism," said ABS Chairman and Chief Executive Officer Alfred J. Roach. "This is just one example of how America and Russia can work together to safeguard the health of people worldwide, especially those who are most vulnerable to international bioterrorism."
ABS' mission was evaluated at the very highest level in the Russian Ministry of Health and the Russian Academy of Agriculture, added Professor Rem V. Petrov, DSc, vice president of the Russian Academy of Sciences speaking on behalf of his colleagues, Professor G. Onishenko, deputy minister of health and Professor G. Romanenko, ...
Source: HighBeam Research, ABS Negotiates Anthrax And Smallpox Vaccine Agreement.(Brief Article)